Skip to main content
Top
Published in: Journal of NeuroEngineering and Rehabilitation 1/2013

Open Access 01-12-2013 | Research

Changes of gait pattern in children with Charcot-Marie-Tooth disease type 1A: a 18 months follow-up study

Authors: Maurizio Ferrarin, Tiziana Lencioni, Marco Rabuffetti, Isabella Moroni, Emanuela Pagliano, Davide Pareyson

Published in: Journal of NeuroEngineering and Rehabilitation | Issue 1/2013

Login to get access

Abstract

Background

In a previous study we identified 3 different gait patterns in a group of children with CMT1A disease: Normal-like (NL), Foot-drop (FD), Foot-drop and Push-off Deficit (FD&POD). Goal of the present study was to perform a follow-up evaluation of the same group of patients to analyze possible changes of gait features in relation to disease progression or specific therapy.

Methods

Nineteen children with CMT1A were evaluated clinically (CMT-Examination Score and Overall Neuropathy Limitation Scale) and through gait analysis 18.2±1.5 months after a baseline evaluation. Meanwhile, 3 of them had foot surgery.

Results

Fifteen out of the 16 non-operated patients significantly changed at least one of the two parameters associated to primary signs (FD and/or POD). Eleven participants worsened at least one parameter and 9 improved one parameter. CMTES significantly worsened for the group of non-operated patients. However, there was no change in CMTES score in 4 patients and in ONLS score in 11. At subgroup level, participants originally belonging to NL group showed a trend towards a foot-drop deficit (−15%, ns); FD and FD&POD subgroups did not change their primary signs, although significant changes were identified individually. All 3 patients operated have improved push-off and proximal joint patterns during walking. Clinical scores did not change within any sub-group.

Conclusions

Subtle changes occurring in 1.5 year in gait features of CMT1A children can be instrumentally identified. Such changes show a large inter-subject variability, with some patients even improving their walking pattern. There is anecdotal evidence that foot surgery may improve the push-off phase of gait.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pareyson D, Marchesi C: Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet Neurol 2009,8(7):654-667. 10.1016/S1474-4422(09)70110-3CrossRefPubMed Pareyson D, Marchesi C: Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet Neurol 2009,8(7):654-667. 10.1016/S1474-4422(09)70110-3CrossRefPubMed
2.
go back to reference Padua L, Pareyson D, Aprile I, Cavallaro T, Quattrone A, Rizzuto N, Vita G, Tonali P, Schenone A: Natural history of CMT1A including QoL: a 2-year prospective study. Neuromuscul Disord 2008,8(3):199-203.CrossRef Padua L, Pareyson D, Aprile I, Cavallaro T, Quattrone A, Rizzuto N, Vita G, Tonali P, Schenone A: Natural history of CMT1A including QoL: a 2-year prospective study. Neuromuscul Disord 2008,8(3):199-203.CrossRef
3.
go back to reference Reilly MM, Shy ME, Muntoni F, Pareyson D: 168th ENMC International Workshop: outcome measures and clinical trials in Charcot-Marie-Tooth disease (CMT). Neuromuscul Disord 2010,20(12):839-846. 10.1016/j.nmd.2010.08.001CrossRefPubMed Reilly MM, Shy ME, Muntoni F, Pareyson D: 168th ENMC International Workshop: outcome measures and clinical trials in Charcot-Marie-Tooth disease (CMT). Neuromuscul Disord 2010,20(12):839-846. 10.1016/j.nmd.2010.08.001CrossRefPubMed
4.
go back to reference Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M: Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 2005,64(7):1209-1214. 10.1212/01.WNL.0000156517.00615.A3CrossRefPubMed Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M: Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 2005,64(7):1209-1214. 10.1212/01.WNL.0000156517.00615.A3CrossRefPubMed
5.
go back to reference Solari A, Laurà M, Salsano E, Radice D, Pareyson D, CMT-TRIAAL Study Group: Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. Neuromuscul Disord 2008,18(1):19-26. 10.1016/j.nmd.2007.09.006CrossRefPubMed Solari A, Laurà M, Salsano E, Radice D, Pareyson D, CMT-TRIAAL Study Group: Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. Neuromuscul Disord 2008,18(1):19-26. 10.1016/j.nmd.2007.09.006CrossRefPubMed
6.
go back to reference Pagliano E, Moroni I, Baranello G, Magro A, Marchi A, Bulgheroni S, Ferrarin M, Pareyson D: Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children. J Peripher Nerv Syst 2011,16(3):237-242. 10.1111/j.1529-8027.2011.00357.xPubMedCentralCrossRefPubMed Pagliano E, Moroni I, Baranello G, Magro A, Marchi A, Bulgheroni S, Ferrarin M, Pareyson D: Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children. J Peripher Nerv Syst 2011,16(3):237-242. 10.1111/j.1529-8027.2011.00357.xPubMedCentralCrossRefPubMed
7.
go back to reference Burns J, Ouvrier R, Estilow T, Shy R, Laurá M, Pallant JF, Lek M, Muntoni F, Reilly MM, Pareyson D, Acsadi G, Shy ME, Finkel RS: Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability. Ann Neurol 2012,71(5):642-652. 10.1002/ana.23572PubMedCentralCrossRefPubMed Burns J, Ouvrier R, Estilow T, Shy R, Laurá M, Pallant JF, Lek M, Muntoni F, Reilly MM, Pareyson D, Acsadi G, Shy ME, Finkel RS: Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability. Ann Neurol 2012,71(5):642-652. 10.1002/ana.23572PubMedCentralCrossRefPubMed
8.
go back to reference Don R, Serrao M, Vinci P, Ranavolo A, Cacchio A, Ioppolo F, Paoloni M, Procaccianti R, Frascarelli F, De Santis F, Pierelli F, Frascarelli M, Santilli V: Foot drop and plantar flexion failure determine different gait strategies in Charcot-Marie-Tooth patients. Clin Biomech (Bristol, Avon) 2007, 22: 905-916. 10.1016/j.clinbiomech.2007.06.002CrossRef Don R, Serrao M, Vinci P, Ranavolo A, Cacchio A, Ioppolo F, Paoloni M, Procaccianti R, Frascarelli F, De Santis F, Pierelli F, Frascarelli M, Santilli V: Foot drop and plantar flexion failure determine different gait strategies in Charcot-Marie-Tooth patients. Clin Biomech (Bristol, Avon) 2007, 22: 905-916. 10.1016/j.clinbiomech.2007.06.002CrossRef
9.
go back to reference Newman CJ, Walsh M, O’Sullivan R, Jenkinson A, Bennett D, Lynch B, O’Brien T: The characteristics of gait in Charcot-Marie-Tooth disease types I and II. Gait Posture 2007, 26: 120-127. 10.1016/j.gaitpost.2006.08.006CrossRefPubMed Newman CJ, Walsh M, O’Sullivan R, Jenkinson A, Bennett D, Lynch B, O’Brien T: The characteristics of gait in Charcot-Marie-Tooth disease types I and II. Gait Posture 2007, 26: 120-127. 10.1016/j.gaitpost.2006.08.006CrossRefPubMed
10.
go back to reference Ferrarin M, Bovi G, Rabuffetti M, Mazzoleni P, Montesano A, Pagliano E, Marchi A, Magro A, Marchesi C, Pareyson D, Moroni I: Gait pattern classification in children with Charcot-Marie-Tooth disease type 1A. Gait Posture 2012,35(1):131-137. 10.1016/j.gaitpost.2011.08.023PubMedCentralCrossRefPubMed Ferrarin M, Bovi G, Rabuffetti M, Mazzoleni P, Montesano A, Pagliano E, Marchi A, Magro A, Marchesi C, Pareyson D, Moroni I: Gait pattern classification in children with Charcot-Marie-Tooth disease type 1A. Gait Posture 2012,35(1):131-137. 10.1016/j.gaitpost.2011.08.023PubMedCentralCrossRefPubMed
11.
go back to reference Vinci P, Paoloni M, Ioppolo F, Gargiulo P, Santilli V: Gait analysis in a patient with severe Charcot-Marie-Tooth disease: a case study with a new orthotic device for footdrop. Eur J Phys Rehabil Med 2010,46(3):355-361.PubMed Vinci P, Paoloni M, Ioppolo F, Gargiulo P, Santilli V: Gait analysis in a patient with severe Charcot-Marie-Tooth disease: a case study with a new orthotic device for footdrop. Eur J Phys Rehabil Med 2010,46(3):355-361.PubMed
12.
go back to reference Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDermott MP: Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology 2008,70(5):378-383. 10.1212/01.wnl.0000297553.36441.ceCrossRefPubMed Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDermott MP: Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology 2008,70(5):378-383. 10.1212/01.wnl.0000297553.36441.ceCrossRefPubMed
13.
go back to reference Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, de Visser M: The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study. Brain 2009,132(Pt 12):3252-3262.CrossRefPubMed Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, de Visser M: The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study. Brain 2009,132(Pt 12):3252-3262.CrossRefPubMed
14.
go back to reference Stansfield BW, Hillman SJ, Hazlewood ME, Lawson AA, Mann AM, Loudon IR, Robb JE: Sagittal joint kinematics, moments, and powers are predominantly characterized by speed of progression, not age, in normal children. J Pediatr Orthop 2001,21(3):403-411.PubMed Stansfield BW, Hillman SJ, Hazlewood ME, Lawson AA, Mann AM, Loudon IR, Robb JE: Sagittal joint kinematics, moments, and powers are predominantly characterized by speed of progression, not age, in normal children. J Pediatr Orthop 2001,21(3):403-411.PubMed
15.
go back to reference Benedetti MG, Catani F, Bilotta TW, Marcacci M, Mariani E, Giannini S: Muscle activation pattern and gait biomechanics after total knee replacement. Clin Biomech (Bristol, Avon) 2003,18(9):871-876. 10.1016/S0268-0033(03)00146-3CrossRef Benedetti MG, Catani F, Bilotta TW, Marcacci M, Mariani E, Giannini S: Muscle activation pattern and gait biomechanics after total knee replacement. Clin Biomech (Bristol, Avon) 2003,18(9):871-876. 10.1016/S0268-0033(03)00146-3CrossRef
16.
go back to reference Bell KJ, Ounpuu S, DeLuca PA, Romness MJ: Natural progression of gait in children with cerebral palsy. J Pediatr Orthop 2002,22(5):677-682.PubMed Bell KJ, Ounpuu S, DeLuca PA, Romness MJ: Natural progression of gait in children with cerebral palsy. J Pediatr Orthop 2002,22(5):677-682.PubMed
17.
go back to reference Rabuffetti M, Crenna P: A modular protocol for the analysis of movement in children. Gait Posture 2004, 20: S77-S78. Rabuffetti M, Crenna P: A modular protocol for the analysis of movement in children. Gait Posture 2004, 20: S77-S78.
18.
go back to reference Burns J, Ouvrier R, Estilow T, Shy R, Laurá M, Eichinger K, Muntoni F, Reilly MM, Pareyson D, Acsadi G, Shy ME, Finkel RS: Symmetry of foot alignment and ankle flexibility in paediatric Charcot-Marie-Tooth disease. Clin Biomech (Bristol, Avon) 2012. Epub ahead of print Burns J, Ouvrier R, Estilow T, Shy R, Laurá M, Eichinger K, Muntoni F, Reilly MM, Pareyson D, Acsadi G, Shy ME, Finkel RS: Symmetry of foot alignment and ankle flexibility in paediatric Charcot-Marie-Tooth disease. Clin Biomech (Bristol, Avon) 2012. Epub ahead of print
19.
go back to reference Beck RJ, Andriacchi TP, Kuo KN, Fermier RW, Galante JO: Changes in the gait patterns of growing children. J Bone Joint Surg Am 1981,63(9):1452-1457.PubMed Beck RJ, Andriacchi TP, Kuo KN, Fermier RW, Galante JO: Changes in the gait patterns of growing children. J Bone Joint Surg Am 1981,63(9):1452-1457.PubMed
20.
go back to reference Hof AL: Scaling gait data to body size. Gait Posture 1996,4(3):222-223. 10.1016/0966-6362(95)01057-2CrossRef Hof AL: Scaling gait data to body size. Gait Posture 1996,4(3):222-223. 10.1016/0966-6362(95)01057-2CrossRef
21.
go back to reference Winter DA: The biomechanics and motor control of human gait: normal, elderly, and pathological. 2nd edition. Waterloo, Ontario: University of Waterloo Press; 1991. Winter DA: The biomechanics and motor control of human gait: normal, elderly, and pathological. 2nd edition. Waterloo, Ontario: University of Waterloo Press; 1991.
22.
go back to reference Ferrarin M, Bovi G, Rabuffetti M, Mazzoleni P, Montesano A, Moroni I, Pagliano E, Marchi A, Marchesi C, Beghi E, Pareyson D: Reliability of instrumented movement analysis as outcome measure in Charcot-Marie-Tooth disease: results from a multitask locomotor protocol. Gait Posture 2011,34(1):36-43. 10.1016/j.gaitpost.2011.03.007PubMedCentralCrossRefPubMed Ferrarin M, Bovi G, Rabuffetti M, Mazzoleni P, Montesano A, Moroni I, Pagliano E, Marchi A, Marchesi C, Beghi E, Pareyson D: Reliability of instrumented movement analysis as outcome measure in Charcot-Marie-Tooth disease: results from a multitask locomotor protocol. Gait Posture 2011,34(1):36-43. 10.1016/j.gaitpost.2011.03.007PubMedCentralCrossRefPubMed
23.
go back to reference Micallef J, Attarian S, Dubourg O, Gonnaud PM, Hogrel JY, Stojkovic T, Bernard R, Jouve E, Pitel S, Vacherot F, Remec JF, Jomir L, Azabou E, Al-Moussawi M, Lefebvre MN, Attolini L, Yaici S, Tanesse D, Fontes M, Pouget J, Blin O: Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2009,8(12):1103-1110. 10.1016/S1474-4422(09)70260-1CrossRefPubMed Micallef J, Attarian S, Dubourg O, Gonnaud PM, Hogrel JY, Stojkovic T, Bernard R, Jouve E, Pitel S, Vacherot F, Remec JF, Jomir L, Azabou E, Al-Moussawi M, Lefebvre MN, Attolini L, Yaici S, Tanesse D, Fontes M, Pouget J, Blin O: Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2009,8(12):1103-1110. 10.1016/S1474-4422(09)70260-1CrossRefPubMed
24.
go back to reference Pareyson D, Reilly MM, Schenone A, Fabrizi GM, Cavallaro T, Santoro L, Vita G, Quattrone A, Padua L, Gemignani F, Visioli F, Laurà M, Radice D, Calabrese D, Hughes RA, Solari A, CMT-TRIAAL; CMT-TRAUK groups: Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol 2011,10(4):320-328. 10.1016/S1474-4422(11)70025-4PubMedCentralCrossRefPubMed Pareyson D, Reilly MM, Schenone A, Fabrizi GM, Cavallaro T, Santoro L, Vita G, Quattrone A, Padua L, Gemignani F, Visioli F, Laurà M, Radice D, Calabrese D, Hughes RA, Solari A, CMT-TRIAAL; CMT-TRAUK groups: Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol 2011,10(4):320-328. 10.1016/S1474-4422(11)70025-4PubMedCentralCrossRefPubMed
25.
go back to reference Graham RC, Hughes RA: A modified peripheral neuropathy scale: the overall neuropathy limitations scale. J Neurol Neurosurg Psychiatry 2006,77(8):973-976. 10.1136/jnnp.2005.081547PubMedCentralCrossRefPubMed Graham RC, Hughes RA: A modified peripheral neuropathy scale: the overall neuropathy limitations scale. J Neurol Neurosurg Psychiatry 2006,77(8):973-976. 10.1136/jnnp.2005.081547PubMedCentralCrossRefPubMed
Metadata
Title
Changes of gait pattern in children with Charcot-Marie-Tooth disease type 1A: a 18 months follow-up study
Authors
Maurizio Ferrarin
Tiziana Lencioni
Marco Rabuffetti
Isabella Moroni
Emanuela Pagliano
Davide Pareyson
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of NeuroEngineering and Rehabilitation / Issue 1/2013
Electronic ISSN: 1743-0003
DOI
https://doi.org/10.1186/1743-0003-10-65

Other articles of this Issue 1/2013

Journal of NeuroEngineering and Rehabilitation 1/2013 Go to the issue